GG 931 (Orphenadrine Citrate Extended-Release 100 mg)
Pill imprint GG 931 has been identified as Orphenadrine citrate extended-release 100 mg.
Orphenadrine is used in the treatment of muscle spasm; migraine and belongs to the drug class skeletal muscle relaxants. Risk cannot be ruled out during pregnancy. Orphenadrine 100 mg is not a controlled substance under the Controlled Substance Act (CSA).
- GG 931
- 100 mg
- Prescription only
- Drug Class:
- Skeletal muscle relaxants
- Pregnancy Category:
- C - Risk cannot be ruled out
- CSA Schedule:
- Not a controlled drug
- National Drug Code (NDC):
|NDC Code||Manufacturer / Repackager|
|43386-0480||Gavis Pharmaceuticals, LLC|
|55045-1325||Dispensing Solutions Inc. (repackager)|
|57866-7601||Direct Dispensing Inc (repackager)|
|10544-0359||Blenheim Pharmacal Inc (repackager)|
Note: Inactive ingredients may vary.
More about orphenadrine
- Orphenadrine extended-release tablets
- Orphenadrine (Advanced Reading)
- Orphenadrine Injection (Advanced Reading)
Related treatment guides
Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.
Copyright 2016 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.